PAX5 and neoplasm: In human B cell acute lymphoblastic leukemia (B-ALL), which is the most common cancer in children, Pax5 is a haploinsufficient tumor suppressor, and the deletion of one Pax5 allele in mice cooperates with oncogenic mutations and with heterozygosity of the transcription factor Ebf1 to drive malignant transformation8–11.